BIOC Historical PE Ratio image   This BIOC PE ratio history page last updated 10/3/2022
BIOC Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q1 2022
5/23/2022
1.48-0.16-0.64NA
Q4 2021
4/6/2022
2.10-0.18-0.72NA
Q3 2021
11/15/2021
3.990.030.1233.2
Q2 2021
8/16/2021
3.79-0.14-0.56NA
Q1 2021
5/12/2021
4.760.190.766.3
Q4 2020
3/29/2021
5.150.140.569.2
Q3 2020
11/12/2020
6.16-0.43-1.72NA
Q2 2020
8/12/2020
10.20-0.50-2.00NA
Q1 2020
5/13/2020
4.40-1.10-4.40NA
Q4 2019
3/25/2020
3.50-2.00-8.00NA
Q3 2019
11/13/2019
6.70-2.50-10.00NA
Q2 2019
8/12/2019
10.90-3.80-15.20NA
Q1 2019
5/8/2019
9.10-6.10-24.40NA
Q4 2018
3/28/2019
11.80-14.30-57.20NA
Q3 2018
11/13/2018
18.00-24.20-96.80NA
Q2 2018
8/14/2018
36.50-27.00-108.00NA
Q1 2018
5/15/2018
66.00-33.00-132.00NA
Q4 2017
3/28/2018
96.00-54.00-216.00NA
Q3 2017
11/9/2017
279.00-60.00-240.00NA
Q2 2017
8/10/2017
435.00-63.00-252.00NA
Q1 2017
5/11/2017
549.00-63.00-252.00NA
Q4 2016
3/7/2017
678.00-81.00-324.00NA
Q3 2016
11/9/2016
237.00-513.00-2052.00NA
Q2 2016
8/2/2016
567.00-180.00-720.00NA
Q1 2016
5/12/2016
729.00-225.00-900.00NA
Q4 2015
3/9/2016
1503.00-216.00-864.00NA
Q3 2015
11/5/2015
2178.00-216.00-864.00NA
Q2 2015
8/10/2015
2016.00-198.00-792.00NA
Q1 2015
5/12/2015
2700.00-333.00-1332.00NA
Q4 2014
3/9/2015
3033.00-783.00-3132.00NA
Q3 2014
11/13/2014
3114.00-783.00-3132.00NA
Q2 2014
8/8/2014
4383.00-603.00-2412.00NA
Q1 2014
2/6/2014
7785.00-1764.00-7056.00NA
Q4 2013
12/31/2013
NA-16533.00-66132.00NA
Q4 2012
2/5/2013
6489.0090.00360.0018.0
Q3 2012
11/12/2012
5175.00-603.00-2412.00NA
Q2 2012
8/8/2012
4680.0054.00216.0021.7
BIOC PE History Chart
PeriodPriceGAAPTTMPE
Q1 2022
5/23/2022
1.48-0.16-0.45NA
Q4 2021
4/6/2022
2.10-0.18-0.10NA
Q3 2021
11/15/2021
3.990.030.2218.1
Q2 2021
8/16/2021
3.79-0.14-0.24NA
Q1 2021
5/12/2021
4.760.19-0.60NA
Q4 2020
3/29/2021
5.150.14-1.89NA
Q3 2020
11/12/2020
6.16-0.43-4.03NA
Q2 2020
8/12/2020
10.20-0.50-6.10NA
Q1 2020
5/13/2020
4.40-1.10-9.40NA
Q4 2019
3/25/2020
3.50-2.00-14.40NA
Q3 2019
11/13/2019
6.70-2.50-26.70NA
Q2 2019
8/12/2019
10.90-3.80-48.40NA
Q1 2019
5/8/2019
9.10-6.10-71.60NA
Q4 2018
3/28/2019
11.80-14.30-98.50NA
Q3 2018
11/13/2018
18.00-24.20-138.20NA
Q2 2018
8/14/2018
36.50-27.00-174.00NA
Q1 2018
5/15/2018
66.00-33.00-210.00NA
Q4 2017
3/28/2018
96.00-54.00-240.00NA
Q3 2017
11/9/2017
279.00-60.00-267.00NA
Q2 2017
8/10/2017
435.00-63.00-720.00NA
Q1 2017
5/11/2017
549.00-63.00-837.00NA
Q4 2016
3/7/2017
678.00-81.00-999.00NA
Q3 2016
11/9/2016
237.00-513.00-1134.00NA
Q2 2016
8/2/2016
567.00-180.00-837.00NA
Q1 2016
5/12/2016
729.00-225.00-855.00NA
Q4 2015
3/9/2016
1503.00-216.00-963.00NA
Q3 2015
11/5/2015
2178.00-216.00-1530.00NA
Q2 2015
8/10/2015
2016.00-198.00-2097.00NA
Q1 2015
5/12/2015
2700.00-333.00-2502.00NA
Q4 2014
3/9/2015
3033.00-783.00-3933.00NA
Q3 2014
11/13/2014
3114.00-783.00-19683.00NA
Q2 2014
8/8/2014
4383.00-603.00-18810.00NA
Q1 2014
2/6/2014
7785.00-1764.00-18810.00NA
Q4 2013
12/31/2013
NA-16533.00-16992.00NA
Q4 2012
2/5/2013
6489.0090.00NANA
Q3 2012
11/12/2012
5175.00-603.00NANA
Q2 2012
8/8/2012
4680.0054.00NANA
Quotes delayed 20 minutes

Email EnvelopeFree BIOC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Biocept (BIOC) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

BIOL PE Ratio History
BIOR PE Ratio History
BIVI PE Ratio History
BKD PE Ratio History
BLCM PE Ratio History
BLFS PE Ratio History
BLI PE Ratio History
BLPH PE Ratio History
BLUE PE Ratio History
BMEA PE Ratio History
How should the BIOC historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Biocept. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this BIOC Historical PE Ratio page.

What is the average historical PE for BIOC based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The BIOC historical PE ratio using the annualized quarterly earnings method works out to 17.7.

What is the average historical PE for BIOC based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The BIOC historical PE ratio using the TTM earnings method works out to 18.1.

On this page we presented the BIOC Historical PE Ratio information for Biocept' stock. The average BIOC historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 17.7. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average BIOC historical PE based on this TTM earnings result method is 18.1. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this BIOC historical PE result, against the recent PE: when this page was posted on 9/30/2022, the most recent closing price for BIOC had been 0.92, and the most recent quarterly earnings result, annualized, was 0.12. Meanwhile, the most recent TTM earnings summed to 0.22. From these numbers, we calculate the recent BIOC PE on 9/30/2022 based on annualized quarterly EPS was 7.7. Based on BIOC's history, that recent PE is low relative to the historical average, with the recent PE 56.5% lower than the historical average PE across our data set for Biocept. Looking at the recent BIOC PE on 9/30/2022 based on TTM EPS, we calculate the ratio at 4.2. Based on BIOC's history, that recent PE is low relative to the historical average, with the recent PE 76.8% lower than the average PE across our Biocept data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on BIOC or any other given stock, valuation analysis for BIOC can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Biocept PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for BIOC. Thanks for visiting, and the next time you need to research BIOC Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: DLR Options Chain, FDX Dividend History, Rezolute Historical Earnings.

 

BIOC Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.